ENTITY
Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (2096 HK)

56
Analysis
Health CareChina
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
more

ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
11 Oct 2020 09:34

A Different Angle - Simcere Pharmaceutical VS Everest Medicines (01952.HK)

Everest Medicines was listed in Hong Kong stock market on October 9, 2020 and closed at HK$72.75 (up 32.27% on the first day) . From the...

Logo
363 Views
Share
10 Oct 2020 17:29

Simcere Pharmaceutical IPO Initiation: A Rough Patch?

The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...

Logo
390 Views
Share
08 Oct 2020 12:29

Simcere (先声制药) Pre-IPO: PHIP Updates and Peer Comparison

Simcere Pharma has a long history dating back to 1995 and was previously listed in the US. The company is looking to raise USD 500m via a listing...

Logo
466 Views
Share
08 Jul 2020 14:37

Simcere (先声制药) Pre-IPO: Long History but Products Concentrated

Simcere Pharma has a long history dating back to 1995 and was previously listed in the US. The company is looking to raise USD 500m via a listing...

Logo
465 Views
Share
x